CEFTAZIDIME DISPOSITION IN ACUTE AND STABLE CYSTIC-FIBROSIS

被引：73

作者：

LEEDER, JS

SPINO, M

ISLES, AF

TESORO, AM

GOLD, R

MACLEOD, SM

机构：

[1] UNIV TORONTO,FAC PHARM,TORONTO M5S 1A1,ONTARIO,CANADA

[2] UNIV TORONTO,FAC MED,TORONTO M5S 1A1,ONTARIO,CANADA

[3] HOSP SICK CHILDREN,DIV CHEST DIS,TORONTO M5G 1X8,ONTARIO,CANADA

[4] HOSP SICK CHILDREN,DIV INFECT DIS,TORONTO M5G 1X8,ONTARIO,CANADA

来源：

关键词：

D O I：

10.1038/clpt.1984.187

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：355 / 362

页数：8

共 35 条

[1] ARVIDSSON A, 1979, CLIN PHARMACOL THER, V25, P870
[2] BAUER LA, 1983, CLIN PHARMACY, V2, P262
[3] BERGAN T, 1979, ARZNEIMITTEL-FORSCH, V29-2, P1955
[4] CARBON C, 1983, 2ND P WORLD C CLIN P
[5] PROGRAM PACKAGE FOR SIMULATION AND PARAMETER-ESTIMATION IN PHARMACOKINETIC SYSTEMS
DARGENIO, DZ
SCHUMITZKY, A
[J]. COMPUTER PROGRAMS IN BIOMEDICINE, 1979, 9 (02): : 115 - 134
[6] DUDUBOIS, 1916, ARCH INTERN MED, V17, P863
[7] AMINOGLYCOSIDE CLEARANCE IN PATIENTS WITH CYSTIC-FIBROSIS
FINKELSTEIN, E
HALL, K
[J]. JOURNAL OF PEDIATRICS, 1979, 94 (01) : 163 - 164
[8] ACTIVITY OF CEFTAZIDIME AGAINST PSEUDOMONAS-AERUGINOSA FROM BACTEREMIC AND FIBROCYSTIC PATIENTS
FLEMING, PC
KNIE, B
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1981, 8 : 169 - 173
[9] CEFTAZIDIME - ASPECTS OF EFFICACY AND TOLERANCE
FOORD, RD
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 : 399 - 403
[10] GIBALDI M, 1982, PHARMACOKINETICS